nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—ALB—membranous glomerulonephritis	0.522	1	CbGaD
Vandetanib—STK10—renal vein—membranous glomerulonephritis	0.0633	0.302	CbGeAlD
Vandetanib—BMPR1B—epithelium—membranous glomerulonephritis	0.00542	0.0258	CbGeAlD
Vandetanib—RIPK2—nephron tubule—membranous glomerulonephritis	0.00434	0.0207	CbGeAlD
Vandetanib—VEGFA—nephron tubule—membranous glomerulonephritis	0.00433	0.0206	CbGeAlD
Vandetanib—FMO1—nephron tubule—membranous glomerulonephritis	0.0043	0.0205	CbGeAlD
Vandetanib—FLT4—epithelium—membranous glomerulonephritis	0.00427	0.0204	CbGeAlD
Vandetanib—RIPK2—epithelium—membranous glomerulonephritis	0.00425	0.0203	CbGeAlD
Vandetanib—ERBB3—nephron tubule—membranous glomerulonephritis	0.00415	0.0198	CbGeAlD
Vandetanib—ERBB3—epithelium—membranous glomerulonephritis	0.00407	0.0194	CbGeAlD
Vandetanib—FMO1—kidney—membranous glomerulonephritis	0.00378	0.018	CbGeAlD
Vandetanib—RET—epithelium—membranous glomerulonephritis	0.00377	0.018	CbGeAlD
Vandetanib—FLT4—cortex of kidney—membranous glomerulonephritis	0.00373	0.0178	CbGeAlD
Vandetanib—VEGFA—cortex of kidney—membranous glomerulonephritis	0.0037	0.0176	CbGeAlD
Vandetanib—SLK—nephron tubule—membranous glomerulonephritis	0.00369	0.0176	CbGeAlD
Vandetanib—FMO1—cortex of kidney—membranous glomerulonephritis	0.00368	0.0176	CbGeAlD
Vandetanib—ERBB3—kidney—membranous glomerulonephritis	0.00365	0.0174	CbGeAlD
Vandetanib—FYN—nephron tubule—membranous glomerulonephritis	0.00359	0.0171	CbGeAlD
Vandetanib—TEK—epithelium—membranous glomerulonephritis	0.00344	0.0164	CbGeAlD
Vandetanib—RET—kidney—membranous glomerulonephritis	0.00338	0.0161	CbGeAlD
Vandetanib—MKNK1—cortex of kidney—membranous glomerulonephritis	0.00334	0.0159	CbGeAlD
Vandetanib—AXL—cortex of kidney—membranous glomerulonephritis	0.00328	0.0156	CbGeAlD
Vandetanib—YES1—nephron tubule—membranous glomerulonephritis	0.00324	0.0154	CbGeAlD
Vandetanib—SLK—cortex of kidney—membranous glomerulonephritis	0.00316	0.0151	CbGeAlD
Vandetanib—FYN—kidney—membranous glomerulonephritis	0.00315	0.015	CbGeAlD
Vandetanib—TEK—kidney—membranous glomerulonephritis	0.00308	0.0147	CbGeAlD
Vandetanib—FYN—cortex of kidney—membranous glomerulonephritis	0.00307	0.0146	CbGeAlD
Vandetanib—SRC—epithelium—membranous glomerulonephritis	0.00305	0.0146	CbGeAlD
Vandetanib—TEK—cortex of kidney—membranous glomerulonephritis	0.003	0.0143	CbGeAlD
Vandetanib—MAP4K5—cortex of kidney—membranous glomerulonephritis	0.003	0.0143	CbGeAlD
Vandetanib—EPHB6—cortex of kidney—membranous glomerulonephritis	0.00287	0.0137	CbGeAlD
Vandetanib—KDR—nephron tubule—membranous glomerulonephritis	0.00287	0.0137	CbGeAlD
Vandetanib—YES1—kidney—membranous glomerulonephritis	0.00285	0.0136	CbGeAlD
Vandetanib—STK10—kidney—membranous glomerulonephritis	0.00282	0.0134	CbGeAlD
Vandetanib—KDR—epithelium—membranous glomerulonephritis	0.00281	0.0134	CbGeAlD
Vandetanib—YES1—cortex of kidney—membranous glomerulonephritis	0.00277	0.0132	CbGeAlD
Vandetanib—SRC—kidney—membranous glomerulonephritis	0.00274	0.0131	CbGeAlD
Vandetanib—KDR—kidney—membranous glomerulonephritis	0.00252	0.012	CbGeAlD
Vandetanib—KDR—cortex of kidney—membranous glomerulonephritis	0.00245	0.0117	CbGeAlD
Vandetanib—MAP2K5—cortex of kidney—membranous glomerulonephritis	0.00245	0.0117	CbGeAlD
Vandetanib—PDGFRB—epithelium—membranous glomerulonephritis	0.00243	0.0116	CbGeAlD
Vandetanib—ABL1—nephron tubule—membranous glomerulonephritis	0.00221	0.0105	CbGeAlD
Vandetanib—PDGFRB—kidney—membranous glomerulonephritis	0.00218	0.0104	CbGeAlD
Vandetanib—PDGFRB—cortex of kidney—membranous glomerulonephritis	0.00212	0.0101	CbGeAlD
Vandetanib—ABL1—kidney—membranous glomerulonephritis	0.00194	0.00926	CbGeAlD
Vandetanib—ABL1—cortex of kidney—membranous glomerulonephritis	0.00189	0.00902	CbGeAlD
Vandetanib—Erlotinib—ALB—membranous glomerulonephritis	0.00174	0.615	CrCbGaD
Vandetanib—ABCC1—cortex of kidney—membranous glomerulonephritis	0.00144	0.00687	CbGeAlD
Vandetanib—ABCG2—nephron tubule—membranous glomerulonephritis	0.00139	0.00665	CbGeAlD
Vandetanib—Gefitinib—ALB—membranous glomerulonephritis	0.00109	0.385	CrCbGaD
Vandetanib—CYP3A4—kidney—membranous glomerulonephritis	0.000854	0.00407	CbGeAlD
Vandetanib—VEGFA—Developmental Biology—MMP9—membranous glomerulonephritis	6.12e-05	0.000231	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CD40—membranous glomerulonephritis	6.11e-05	0.000231	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—HLA-DRB1—membranous glomerulonephritis	6.09e-05	0.00023	CbGpPWpGaD
Vandetanib—FYN—Axon guidance—MMP9—membranous glomerulonephritis	6.08e-05	0.00023	CbGpPWpGaD
Vandetanib—LCK—Cytokine Signaling in Immune system—IL1B—membranous glomerulonephritis	6.03e-05	0.000228	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—HLA-DRB1—membranous glomerulonephritis	5.99e-05	0.000226	CbGpPWpGaD
Vandetanib—LYN—Immune System—CD40—membranous glomerulonephritis	5.98e-05	0.000226	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PLA2G1B—membranous glomerulonephritis	5.98e-05	0.000226	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—PLG—membranous glomerulonephritis	5.97e-05	0.000225	CbGpPWpGaD
Vandetanib—SRC—Disease—LRP2—membranous glomerulonephritis	5.96e-05	0.000225	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CD40—membranous glomerulonephritis	5.95e-05	0.000225	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—C3—membranous glomerulonephritis	5.92e-05	0.000223	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—MMP9—membranous glomerulonephritis	5.91e-05	0.000223	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	5.91e-05	0.000223	CbGpPWpGaD
Vandetanib—FYN—Immune System—CD40—membranous glomerulonephritis	5.89e-05	0.000222	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—LRP2—membranous glomerulonephritis	5.88e-05	0.000222	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	5.84e-05	0.00022	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—APOA1—membranous glomerulonephritis	5.83e-05	0.00022	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—LRP2—membranous glomerulonephritis	5.75e-05	0.000217	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—RHOA—membranous glomerulonephritis	5.74e-05	0.000217	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CD79A—membranous glomerulonephritis	5.74e-05	0.000217	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—C3—membranous glomerulonephritis	5.7e-05	0.000215	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—C3—membranous glomerulonephritis	5.68e-05	0.000214	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—APOE—membranous glomerulonephritis	5.67e-05	0.000214	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—LRP2—membranous glomerulonephritis	5.66e-05	0.000214	CbGpPWpGaD
Vandetanib—SRC—Axon guidance—RHOA—membranous glomerulonephritis	5.64e-05	0.000213	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—HLA-DRB1—membranous glomerulonephritis	5.64e-05	0.000213	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—ALB—membranous glomerulonephritis	5.63e-05	0.000213	CbGpPWpGaD
Vandetanib—LYN—Immune System—CD79A—membranous glomerulonephritis	5.62e-05	0.000212	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—ALB—membranous glomerulonephritis	5.61e-05	0.000212	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—APOA1—membranous glomerulonephritis	5.61e-05	0.000212	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CD79A—membranous glomerulonephritis	5.6e-05	0.000211	CbGpPWpGaD
Vandetanib—ABCC1—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	5.55e-05	0.00021	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—RHOA—membranous glomerulonephritis	5.55e-05	0.000209	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—ALB—membranous glomerulonephritis	5.55e-05	0.000209	CbGpPWpGaD
Vandetanib—FYN—Immune System—CD79A—membranous glomerulonephritis	5.54e-05	0.000209	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—RHOA—membranous glomerulonephritis	5.52e-05	0.000209	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CD40LG—membranous glomerulonephritis	5.48e-05	0.000207	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—C3—membranous glomerulonephritis	5.47e-05	0.000207	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—RHOA—membranous glomerulonephritis	5.46e-05	0.000206	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—LRP2—membranous glomerulonephritis	5.46e-05	0.000206	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—PLG—membranous glomerulonephritis	5.46e-05	0.000206	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—MMP9—membranous glomerulonephritis	5.45e-05	0.000206	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—RHOA—membranous glomerulonephritis	5.44e-05	0.000206	CbGpPWpGaD
Vandetanib—YES1—Immune System—C3—membranous glomerulonephritis	5.43e-05	0.000205	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—RHOA—membranous glomerulonephritis	5.42e-05	0.000205	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—RHOA—membranous glomerulonephritis	5.36e-05	0.000202	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—PLG—membranous glomerulonephritis	5.32e-05	0.000201	CbGpPWpGaD
Vandetanib—ERBB3—Disease—APOE—membranous glomerulonephritis	5.32e-05	0.000201	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—HLA-DQA1—membranous glomerulonephritis	5.3e-05	0.0002	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—PLG—membranous glomerulonephritis	5.27e-05	0.000199	CbGpPWpGaD
Vandetanib—ERBB3—Disease—APOA1—membranous glomerulonephritis	5.26e-05	0.000199	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PLA2G1B—membranous glomerulonephritis	5.26e-05	0.000199	CbGpPWpGaD
Vandetanib—EGFR—Axon guidance—MMP9—membranous glomerulonephritis	5.25e-05	0.000198	CbGpPWpGaD
Vandetanib—LYN—Immune System—HLA-DQA1—membranous glomerulonephritis	5.19e-05	0.000196	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—HLA-DRB1—membranous glomerulonephritis	5.18e-05	0.000195	CbGpPWpGaD
Vandetanib—ALB—Platelet activation, signaling and aggregation—RHOA—membranous glomerulonephritis	5.18e-05	0.000195	CbGpPWpGaD
Vandetanib—ABL1—Immune System—HLA-DQA1—membranous glomerulonephritis	5.17e-05	0.000195	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—APOA1—membranous glomerulonephritis	5.16e-05	0.000195	CbGpPWpGaD
Vandetanib—FYN—Immune System—HLA-DQA1—membranous glomerulonephritis	5.11e-05	0.000193	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD40—membranous glomerulonephritis	5.09e-05	0.000192	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—C3—membranous glomerulonephritis	5.05e-05	0.000191	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—HLA-DRB1—membranous glomerulonephritis	4.99e-05	0.000188	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—MMP9—membranous glomerulonephritis	4.99e-05	0.000188	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—PLG—membranous glomerulonephritis	4.98e-05	0.000188	CbGpPWpGaD
Vandetanib—YES1—Immune System—HLA-DRB1—membranous glomerulonephritis	4.95e-05	0.000187	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD40—membranous glomerulonephritis	4.9e-05	0.000185	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—LRP2—membranous glomerulonephritis	4.89e-05	0.000185	CbGpPWpGaD
Vandetanib—ABCG2—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	4.89e-05	0.000184	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	4.88e-05	0.000184	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—C3—membranous glomerulonephritis	4.85e-05	0.000183	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—PLG—membranous glomerulonephritis	4.79e-05	0.000181	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD79A—membranous glomerulonephritis	4.78e-05	0.000181	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—RHOA—membranous glomerulonephritis	4.76e-05	0.00018	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—RHOA—membranous glomerulonephritis	4.72e-05	0.000178	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—LRP2—membranous glomerulonephritis	4.72e-05	0.000178	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CD40LG—membranous glomerulonephritis	4.68e-05	0.000177	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	4.63e-05	0.000175	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—PLG—membranous glomerulonephritis	4.62e-05	0.000174	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—ALB—membranous glomerulonephritis	4.62e-05	0.000174	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD79A—membranous glomerulonephritis	4.61e-05	0.000174	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—IL1B—membranous glomerulonephritis	4.61e-05	0.000174	CbGpPWpGaD
Vandetanib—LYN—Immune System—CD40LG—membranous glomerulonephritis	4.58e-05	0.000173	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CD40LG—membranous glomerulonephritis	4.56e-05	0.000172	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—MMP9—membranous glomerulonephritis	4.56e-05	0.000172	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—C3—membranous glomerulonephritis	4.54e-05	0.000171	CbGpPWpGaD
Vandetanib—FYN—Immune System—CD40LG—membranous glomerulonephritis	4.51e-05	0.00017	CbGpPWpGaD
Vandetanib—SRC—Axon guidance—MMP9—membranous glomerulonephritis	4.48e-05	0.000169	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—RHOA—membranous glomerulonephritis	4.46e-05	0.000168	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—ALB—membranous glomerulonephritis	4.44e-05	0.000168	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—HLA-DRB1—membranous glomerulonephritis	4.42e-05	0.000167	CbGpPWpGaD
Vandetanib—EGFR—Immune System—HLA-DQA1—membranous glomerulonephritis	4.41e-05	0.000167	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—MMP9—membranous glomerulonephritis	4.41e-05	0.000166	CbGpPWpGaD
Vandetanib—ABCC1—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	4.4e-05	0.000166	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—MMP9—membranous glomerulonephritis	4.39e-05	0.000166	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD40—membranous glomerulonephritis	4.34e-05	0.000164	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—MMP9—membranous glomerulonephritis	4.34e-05	0.000164	CbGpPWpGaD
Vandetanib—ALB—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	4.31e-05	0.000163	CbGpPWpGaD
Vandetanib—LCK—Immune System—HLA-DQA1—membranous glomerulonephritis	4.25e-05	0.000161	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—APOE—membranous glomerulonephritis	4.23e-05	0.00016	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—APOA1—membranous glomerulonephritis	4.18e-05	0.000158	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—LRP2—membranous glomerulonephritis	4.17e-05	0.000158	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—IL1B—membranous glomerulonephritis	4.17e-05	0.000157	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—C3—membranous glomerulonephritis	4.15e-05	0.000157	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—C3—membranous glomerulonephritis	4.14e-05	0.000156	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—ALB—membranous glomerulonephritis	4.09e-05	0.000154	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD79A—membranous glomerulonephritis	4.08e-05	0.000154	CbGpPWpGaD
Vandetanib—LYN—Immune System—C3—membranous glomerulonephritis	4.05e-05	0.000153	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—C3—membranous glomerulonephritis	4.05e-05	0.000153	CbGpPWpGaD
Vandetanib—ABL1—Immune System—C3—membranous glomerulonephritis	4.03e-05	0.000152	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—RHOA—membranous glomerulonephritis	4.03e-05	0.000152	CbGpPWpGaD
Vandetanib—ERBB3—Disease—RHOA—membranous glomerulonephritis	4.03e-05	0.000152	CbGpPWpGaD
Vandetanib—BLK—Immune System—IL1B—membranous glomerulonephritis	4.01e-05	0.000151	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—C3—membranous glomerulonephritis	4e-05	0.000151	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—ABCA1—membranous glomerulonephritis	4e-05	0.000151	CbGpPWpGaD
Vandetanib—FGR—Immune System—IL1B—membranous glomerulonephritis	3.99e-05	0.000151	CbGpPWpGaD
Vandetanib—FYN—Immune System—C3—membranous glomerulonephritis	3.99e-05	0.000151	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—RHOA—membranous glomerulonephritis	3.95e-05	0.000149	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD40LG—membranous glomerulonephritis	3.9e-05	0.000147	CbGpPWpGaD
Vandetanib—ABCG2—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	3.87e-05	0.000146	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—APOE—membranous glomerulonephritis	3.86e-05	0.000146	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—APOA1—membranous glomerulonephritis	3.82e-05	0.000144	CbGpPWpGaD
Vandetanib—ALB—Metabolism—TBXAS1—membranous glomerulonephritis	3.78e-05	0.000143	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—MMP9—membranous glomerulonephritis	3.78e-05	0.000143	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—C3—membranous glomerulonephritis	3.77e-05	0.000142	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—HLA-DRB1—membranous glomerulonephritis	3.77e-05	0.000142	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—APOE—membranous glomerulonephritis	3.77e-05	0.000142	CbGpPWpGaD
Vandetanib—SRC—Immune System—HLA-DQA1—membranous glomerulonephritis	3.77e-05	0.000142	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD40LG—membranous glomerulonephritis	3.76e-05	0.000142	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—MMP9—membranous glomerulonephritis	3.75e-05	0.000141	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—APOE—membranous glomerulonephritis	3.73e-05	0.000141	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—APOA1—membranous glomerulonephritis	3.72e-05	0.000141	CbGpPWpGaD
Vandetanib—LYN—Immune System—HLA-DRB1—membranous glomerulonephritis	3.69e-05	0.000139	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—APOA1—membranous glomerulonephritis	3.68e-05	0.000139	CbGpPWpGaD
Vandetanib—ABL1—Immune System—HLA-DRB1—membranous glomerulonephritis	3.67e-05	0.000139	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IL1B—membranous glomerulonephritis	3.67e-05	0.000139	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—C3—membranous glomerulonephritis	3.64e-05	0.000137	CbGpPWpGaD
Vandetanib—FYN—Immune System—HLA-DRB1—membranous glomerulonephritis	3.63e-05	0.000137	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—APOE—membranous glomerulonephritis	3.56e-05	0.000134	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—ABCA1—membranous glomerulonephritis	3.52e-05	0.000133	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—PLG—membranous glomerulonephritis	3.52e-05	0.000133	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—APOA1—membranous glomerulonephritis	3.52e-05	0.000133	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—C3—membranous glomerulonephritis	3.51e-05	0.000133	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—APOA1—membranous glomerulonephritis	3.48e-05	0.000131	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—PLG—membranous glomerulonephritis	3.45e-05	0.00013	CbGpPWpGaD
Vandetanib—EGFR—Immune System—C3—membranous glomerulonephritis	3.45e-05	0.00013	CbGpPWpGaD
Vandetanib—FYN—Disease—APOE—membranous glomerulonephritis	3.43e-05	0.000129	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—PLG—membranous glomerulonephritis	3.39e-05	0.000128	CbGpPWpGaD
Vandetanib—FYN—Disease—APOA1—membranous glomerulonephritis	3.39e-05	0.000128	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—APOE—membranous glomerulonephritis	3.39e-05	0.000128	CbGpPWpGaD
Vandetanib—ALB—Metabolism—LRP2—membranous glomerulonephritis	3.37e-05	0.000127	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—APOA1—membranous glomerulonephritis	3.35e-05	0.000126	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD40LG—membranous glomerulonephritis	3.33e-05	0.000126	CbGpPWpGaD
Vandetanib—LCK—Immune System—C3—membranous glomerulonephritis	3.32e-05	0.000125	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—APOE—membranous glomerulonephritis	3.27e-05	0.000123	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PLA2G1B—membranous glomerulonephritis	3.24e-05	0.000122	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—APOA1—membranous glomerulonephritis	3.23e-05	0.000122	CbGpPWpGaD
Vandetanib—YES1—Immune System—IL1B—membranous glomerulonephritis	3.22e-05	0.000122	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	3.21e-05	0.000121	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—RHOA—membranous glomerulonephritis	3.2e-05	0.000121	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—MMP9—membranous glomerulonephritis	3.2e-05	0.000121	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	3.17e-05	0.00012	CbGpPWpGaD
Vandetanib—ABCC1—Disease—APOE—membranous glomerulonephritis	3.14e-05	0.000119	CbGpPWpGaD
Vandetanib—EGFR—Immune System—HLA-DRB1—membranous glomerulonephritis	3.14e-05	0.000118	CbGpPWpGaD
Vandetanib—ABCC1—Disease—APOA1—membranous glomerulonephritis	3.11e-05	0.000117	CbGpPWpGaD
Vandetanib—LCK—Immune System—HLA-DRB1—membranous glomerulonephritis	3.03e-05	0.000114	CbGpPWpGaD
Vandetanib—ALB—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	3.02e-05	0.000114	CbGpPWpGaD
Vandetanib—EGFR—Disease—APOE—membranous glomerulonephritis	2.96e-05	0.000112	CbGpPWpGaD
Vandetanib—SRC—Immune System—C3—membranous glomerulonephritis	2.94e-05	0.000111	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—PLG—membranous glomerulonephritis	2.93e-05	0.000111	CbGpPWpGaD
Vandetanib—EGFR—Disease—APOA1—membranous glomerulonephritis	2.93e-05	0.000111	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—RHOA—membranous glomerulonephritis	2.93e-05	0.00011	CbGpPWpGaD
Vandetanib—LCK—Disease—APOE—membranous glomerulonephritis	2.85e-05	0.000108	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—RHOA—membranous glomerulonephritis	2.85e-05	0.000108	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PLG—membranous glomerulonephritis	2.82e-05	0.000107	CbGpPWpGaD
Vandetanib—LCK—Disease—APOA1—membranous glomerulonephritis	2.82e-05	0.000107	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—RHOA—membranous glomerulonephritis	2.82e-05	0.000106	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—RHOA—membranous glomerulonephritis	2.69e-05	0.000102	CbGpPWpGaD
Vandetanib—SRC—Immune System—HLA-DRB1—membranous glomerulonephritis	2.68e-05	0.000101	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—C3—membranous glomerulonephritis	2.68e-05	0.000101	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—RHOA—membranous glomerulonephritis	2.67e-05	0.000101	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—RHOA—membranous glomerulonephritis	2.66e-05	0.0001	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—APOE—membranous glomerulonephritis	2.63e-05	9.93e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—C3—membranous glomerulonephritis	2.62e-05	9.89e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—APOA1—membranous glomerulonephritis	2.6e-05	9.82e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—RHOA—membranous glomerulonephritis	2.6e-05	9.8e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—C3—membranous glomerulonephritis	2.58e-05	9.73e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—RHOA—membranous glomerulonephritis	2.56e-05	9.67e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—MMP9—membranous glomerulonephritis	2.54e-05	9.59e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—APOE—membranous glomerulonephritis	2.53e-05	9.54e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PLG—membranous glomerulonephritis	2.5e-05	9.44e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—APOA1—membranous glomerulonephritis	2.5e-05	9.43e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—APOE—membranous glomerulonephritis	2.49e-05	9.4e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—RHOA—membranous glomerulonephritis	2.48e-05	9.34e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—APOA1—membranous glomerulonephritis	2.46e-05	9.29e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL1B—membranous glomerulonephritis	2.46e-05	9.27e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—APOE—membranous glomerulonephritis	2.44e-05	9.2e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—APOA1—membranous glomerulonephritis	2.41e-05	9.1e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL1B—membranous glomerulonephritis	2.4e-05	9.08e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—APOE—membranous glomerulonephritis	2.4e-05	9.06e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL1B—membranous glomerulonephritis	2.39e-05	9.03e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—RHOA—membranous glomerulonephritis	2.38e-05	8.98e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—APOA1—membranous glomerulonephritis	2.37e-05	8.96e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL1B—membranous glomerulonephritis	2.37e-05	8.93e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MMP9—membranous glomerulonephritis	2.32e-05	8.77e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—APOE—membranous glomerulonephritis	2.32e-05	8.74e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—APOA1—membranous glomerulonephritis	2.29e-05	8.64e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MMP9—membranous glomerulonephritis	2.26e-05	8.55e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—RHOA—membranous glomerulonephritis	2.24e-05	8.46e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MMP9—membranous glomerulonephritis	2.24e-05	8.45e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—C3—membranous glomerulonephritis	2.23e-05	8.41e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—ABCA1—membranous glomerulonephritis	2.17e-05	8.2e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—RHOA—membranous glomerulonephritis	2.16e-05	8.16e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—C3—membranous glomerulonephritis	2.15e-05	8.1e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—APOE—membranous glomerulonephritis	2.07e-05	7.83e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—ALB—membranous glomerulonephritis	2.06e-05	7.78e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—APOA1—membranous glomerulonephritis	2.05e-05	7.74e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL1B—membranous glomerulonephritis	2.04e-05	7.72e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—TBXAS1—membranous glomerulonephritis	2.04e-05	7.71e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MMP9—membranous glomerulonephritis	2.03e-05	7.68e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—APOE—membranous glomerulonephritis	2e-05	7.54e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—APOA1—membranous glomerulonephritis	1.98e-05	7.46e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL1B—membranous glomerulonephritis	1.97e-05	7.44e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MMP9—membranous glomerulonephritis	1.97e-05	7.42e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—RHOA—membranous glomerulonephritis	1.91e-05	7.22e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—C3—membranous glomerulonephritis	1.9e-05	7.17e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—RHOA—membranous glomerulonephritis	1.89e-05	7.12e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—RHOA—membranous glomerulonephritis	1.85e-05	6.97e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—LRP2—membranous glomerulonephritis	1.82e-05	6.87e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—RHOA—membranous glomerulonephritis	1.82e-05	6.86e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—ALB—membranous glomerulonephritis	1.81e-05	6.85e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—APOE—membranous glomerulonephritis	1.77e-05	6.68e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PLA2G1B—membranous glomerulonephritis	1.75e-05	6.61e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—APOA1—membranous glomerulonephritis	1.75e-05	6.6e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL1B—membranous glomerulonephritis	1.74e-05	6.59e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—RHOA—membranous glomerulonephritis	1.57e-05	5.93e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—RHOA—membranous glomerulonephritis	1.51e-05	5.71e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MMP9—membranous glomerulonephritis	1.5e-05	5.65e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MMP9—membranous glomerulonephritis	1.47e-05	5.53e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MMP9—membranous glomerulonephritis	1.44e-05	5.45e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—APOE—membranous glomerulonephritis	1.43e-05	5.39e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—APOA1—membranous glomerulonephritis	1.41e-05	5.33e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—RHOA—membranous glomerulonephritis	1.34e-05	5.06e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MMP9—membranous glomerulonephritis	1.25e-05	4.71e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MMP9—membranous glomerulonephritis	1.2e-05	4.53e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ABCA1—membranous glomerulonephritis	1.17e-05	4.43e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MMP9—membranous glomerulonephritis	1.06e-05	4.01e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—APOE—membranous glomerulonephritis	7.71e-06	2.91e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—APOA1—membranous glomerulonephritis	7.62e-06	2.88e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ALB—membranous glomerulonephritis	6.04e-06	2.28e-05	CbGpPWpGaD
